Compare Expeditors International of Wshngtn Inc (EXPD) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expeditors International of Wshngtn Inc vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Expeditors International of Wshngtn Inc trades at $196.77 (market cap $25.53B), while GE HealthCare Technologies Inc. Common Stock trades at $70.77 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Expeditors International of Wshngtn Inc pays the higher dividend (0.82%). Which is the better fit depends on your goals.
| EXPD | GEHC | |
|---|---|---|
Market Cap | $25.53B | $30.93B |
Volume | 1,068,336 | 5,033,451 |
Sector | Industrials | Health |
52-Week High | $196.38 | $88.16 |
52-Week Low | $117.35 | $59.48 |
Typical Hold Time | 44 Days | — |
Enterprise Value | $25.06B | $39.39B |
Dividend Yield | 0.82% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $195.13, up 0.89% with a bullish technical signal supported by moving averages. The company shows strong profitability with 7.63% net margin and 42.6% ROE, though revenue growth has been modest. Recent earnings beats and positive analyst coverage highlight operational efficiency, while institutional activity shows mixed positioning.
Outlook remains cautiously optimistic with upside to the $220 high target, but valuation multiples appear stretched. Key risks include freight market volatility and competitive pressures. The stock's current price above consensus target suggests limited near-term upside despite strong fundamentals.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
